Valuation: Net Medical Xpress Solutions, Inc.

Market Cap 1.07M 929K 867K 796K 1.5M 102M 1.52M 10.18M 3.99M 51.22M 4.03M 3.94M 169M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 715K 668K 613K 1.15M 78.67M 1.17M 7.83M 3.07M 39.43M 3.1M 3.04M 130M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
1 day+0.14%
1 week-0.14%
Current month-0.14%
6 months+133.33%
Current year+133.33%
1 month 0
Extreme 0.0007
0
Current year 0
Extreme 0.0004
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.03
5 years 0
Extreme 1.0E-6
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 26/06/2019
Director TitleAgeSince
Director/Board Member 64 01/01/2003
Director/Board Member 84 01/01/2005
Director/Board Member - 01/03/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%-0.14%+600.00%-96.50% 26.4K
+0.03%+7.59%-4.22%+53.35% 3,713B
+10.32%+39.78%-8.00%+909.45% 413B
+0.24%-0.23%-3.64%+48.19% 93.42B
+2.02%-12.70%+78.70%+165.71% 84B
+2.47%+7.00%-32.84%-4.59% 79.65B
+2.19%+6.27%-23.16%+97.85% 69.47B
+6.04%+1.47%+13.40%+75.90% 46.09B
+35.31%+47.57%-11.30%-23.99% 37.83B
+24.89%+22.26%+144.53%+313.15% 36.62B
Average +8.36%+12.30%+75.35%+153.85% 457.31B
Weighted average by Cap. +1.63%+10.40%-2.51%+134.02%

Financials

2015 2016
Net sales 4.22M 3.65M 3.41M 3.13M 5.88M 402M 5.98M 40.01M 15.7M 201M 15.85M 15.51M 666M 3.04M 2.63M 2.46M 2.26M 4.24M 290M 4.31M 28.86M 11.33M 145M 11.43M 11.18M 480M
Net income 151K 131K 122K 112K 210K 14.37M 214K 1.43M 562K 7.2M 567K 555K 23.81M -344K -298K -278K -255K -479K -32.74M -487K -3.26M -1.28M -16.41M -1.29M -1.26M -54.25M
Net Debt -340K -294K -275K -252K -474K -32.36M -481K -3.22M -1.26M -16.22M -1.28M -1.25M -53.62M -247K -214K -200K -183K -344K -23.51M -350K -2.34M -919K -11.78M -928K -907K -38.95M
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
  1. Stock Market
  2. Stocks
  3. NMXS Stock